Mary Gray, | |
4010 Dupont Cir Ste 562, Louisville, KY 40207-4888 | |
(502) 896-1850 | |
Not Available |
Full Name | Mary Gray |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 4010 Dupont Cir Ste 562, Louisville, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003136292 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Secondary |
1041C0700X | Social Worker - Clinical | 3758 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mary Gray, 4010 Dupont Cir Ste 562, Louisville, KY 40207-4888 Ph: (502) 896-1850 | Mary Gray, 4010 Dupont Cir Ste 562, Louisville, KY 40207-4888 Ph: (502) 896-1850 |
News Archive
Abbott and the University of Illinois at Urbana-Champaign announced today they have established the first-ever multi-disciplinary nutrition and cognition research center, which will be located on the Urbana campus.
Infection with human immunodeficiency virus (HIV) is no longer an automatic death sentence, thanks to the use of highly active anti-retroviral therapy (HAART).
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
The use of medical cannabis for severe childhood epilepsy may be linked to early puberty, doctors have warned in the journal BMJ Case Reports after treating a 2 year old boy with the condition
› Verified 8 days ago